These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3079086)

  • 1. Histologic response to OKT3 therapy for hepatic allograft rejection.
    Rohrer RJ; Jenkins RL; Khettry U; Benotti PN; Dodson TF; Karlson CG; Georgi BA; Monaco AP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2459-61. PubMed ID: 3079086
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistology of liver allografts in recipients managed with prophylactic OKT3.
    Rohrer RJ; Jenkins RL; Khettry U; Pinson CW; Gallik-Karlson C; Monaco AP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2249-50. PubMed ID: 2652729
    [No Abstract]   [Full Text] [Related]  

  • 3. Low serum OKT3 levels correlate with failure to prevent rejection in orthotopic liver transplant patients.
    McDiarmid SV; Millis M; Terashita G; Ament ME; Busuttil R; Terasaki P
    Transplant Proc; 1990 Aug; 22(4):1774-6. PubMed ID: 2117806
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection.
    Cosimi AB; Cho SI; Delmonico FL; Kaplan MM; Rohrer RJ; Jenkins RL
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2431-3. PubMed ID: 3079083
    [No Abstract]   [Full Text] [Related]  

  • 5. Concomitant low-dose cyclosporine and OKT3 therapy for renal transplant rejection.
    Hricik DE; Zarconi J; Schulak JA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1755-7. PubMed ID: 2652574
    [No Abstract]   [Full Text] [Related]  

  • 6. Single center randomized trial using ATG v OKT3 treatment in steroid resistant rejection crises after kidney transplantation.
    Blümke M; Kirste G; Wanner U; Wilms H
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1747. PubMed ID: 2652571
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of azathioprine and cyclosporine in liver transplantation: a study of two personal series.
    Krom RA; Wiesner RH; Haagsma EB; Ludwig J; Gips CH; Grond AJ; Houthoff HJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2440-2. PubMed ID: 3079085
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocyte parameters in liver graft recipients receiving prophylactic OKT3 or conventional triple therapy.
    Hamilton G; Mühlbacher F; Steininger R; Havel M; Kreuzer S; Laengle F; Piza F
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2255-6. PubMed ID: 2652732
    [No Abstract]   [Full Text] [Related]  

  • 9. OKT3 immunoprophylaxis in human liver transplantation.
    Mühlbacher F; Steininger R; Längle F; Sautner T; Gnant M; Götzinger P; Piza F; Popow T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2253-4. PubMed ID: 2652731
    [No Abstract]   [Full Text] [Related]  

  • 10. Preservation of renal function using OKT3 in liver transplant patients.
    Millis JM; Baquerizo A; Saleh S; Danovitch GM; Busuttil RW
    Transplant Proc; 1989 Jun; 21(3):3551-2. PubMed ID: 2662524
    [No Abstract]   [Full Text] [Related]  

  • 11. Results and problems in pediatric liver transplantation in the Cambridge/Kings College Hospital series: 1968 to July 1986.
    Jamieson NV; Calne RY; Rolles K; Barnes ND; Mowat AP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2447-8. PubMed ID: 3274534
    [No Abstract]   [Full Text] [Related]  

  • 12. OKT3 therapy for hepatic allograft rejection: comparison of results in adults and children.
    Woodle ES; Thistlethwaite JR; Emond JC; Whitington PF; Black DD; Aran PP; Baker AL; Stuart FP; Broelsch CE
    Transplant Proc; 1990 Aug; 22(4):1765-6. PubMed ID: 2117803
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical development of Orthoclone OKT3.
    Cosimi AB
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):7-16. PubMed ID: 3105142
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma levels of leukotriene B4 during hepatic allograft rejection.
    González J; Pardo F; Cienfuegos JA; Hernández JL; de Villa V; Torramadé J; Diaz MC; Pardo FJ; Ortigosa CR
    Transplant Proc; 1992 Feb; 24(1):143-4. PubMed ID: 1311470
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of CyA, OKT3, and ATG immunoprophylaxis in human liver transplantation.
    Steininger R; Mühlbacher F; Hamilton G; Längle F; Gnant M; Popow T; Sautner T; Götzinger P; Wamser P; Stockenhuber F
    Transplant Proc; 1991 Aug; 23(4):2269-71. PubMed ID: 1908154
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver allograft rejection: analysis of OKT3 rescue therapy.
    McCaughan GW; Strasser S; Dolan P; Sheil AG
    Transplant Proc; 1992 Oct; 24(5):2250-1. PubMed ID: 1413044
    [No Abstract]   [Full Text] [Related]  

  • 17. Rescue of severe steroid-resistant rejection with OKT3.PAN.
    Ponticelli C; Rivolta E; Tarantino A; De Vecchi A; Vegeto A
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1908-9. PubMed ID: 3274449
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunobiology of hepatic nonparenchymal cells and ex vivo perfusion of the livers with anti-class II antibody: a strategy to prevent hepatic rejection in the dog.
    Sakagami K; Kurozumi Y; Tanakaya K; Saito S; Fujiwara T; Inagaki M; Matsuno T; Takasu S; Higaki K; Toda K
    Transplant Proc; 1995 Feb; 27(1):533-6. PubMed ID: 7879090
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
    Woodle ES; So S; Jendrisak MD; Perdrizet GA; White HM; Marsh JW
    Transplant Proc; 1993 Apr; 25(2):1988-9. PubMed ID: 7682358
    [No Abstract]   [Full Text] [Related]  

  • 20. Ex vivo perfusion of livers with anti-class II antibody and acute rejection in canine liver transplantation.
    Sakagami K; Saito S; Kurozumi Y; Kobayashi N; Fujiwara T; Matsuno T; Orita K
    Transplant Proc; 1993 Apr; 25(2):1959-61. PubMed ID: 8470243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.